日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma

CAR-NK细胞疗法联合免疫检查点抑制剂可诱导胶质母细胞瘤中NKT细胞反应。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-02977-8
Strassheimer, F; Elleringmann, P; Ludmirski, G; Roller, B; Macas, J; Alekseeva, T; Cakmak, P; Aliraj, B; Krenzlin, H; Demes, M C; Mildenberger, I C; Tonn, T; Weber, K J; Reiss, Y; Plate, K H; Weigert, A; Wels, W S; Steinbach, J P; Burger, M C
T细胞
T细胞
细胞生物学
CAR-NK
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

bemcentinib治疗对去甲基化药物治疗无效的晚期骨髓增生异常肿瘤或急性髓系白血病患者的疗效和安全性——EMSCO II期BERGAMO试验

期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-023-02029-1
Kubasch, A S; Peterlin, P; Cluzeau, T; Götze, K S; Sockel, K; Teipel, R; Jentzsch, M; Attalah, H; Sebert, M; Chermat, F; Gloaguen, S; Puttrich, M; Cross, M; Schneider, M; Kayser, S; Schipp, D; Giagounidis, A; Tirado-Gonzalez, I; Descot, A; van de Loosdrecht, A; Weigert, A; Metzeler, K H; Fenaux, P; Medyouf, H; Platzbecker, U; Ades, L
ERG
表观遗传
白血病
肿瘤
多发性硬化症
肿瘤免疫
发表日期：2023
文献求助 收藏

Use of Pre- and Intensified Postprocedural Physiotherapy in Patients with Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Study (the 4P-TAVR Study)

经导管主动脉瓣置换术治疗有症状主动脉瓣狭窄患者的术前和术后强化物理治疗应用研究（4P-TAVR 研究）

期刊:Journal of Interventional Cardiology
影响因子:1.7
doi:10.1155/2021/8894223
Weber, M; Klein, U; Weigert, A; Schiller, W; Bayley-Ezziddin, V; Wirtz, D C; Welz, A; Werner, N; Grube, E; Nickenig, G; Sinning, J-M; Ghanem, A
发表日期：2021
文献求助 收藏

Identification of IRF1 as critical dual regulator of Smac mimetic-induced apoptosis and inflammatory cytokine response.

鉴定 IRF1 为 Smac 模拟物诱导细胞凋亡和炎症细胞因子反应的关键双重调节因子

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/cddis.2014.498
Eckhardt I, Weigert A, Fulda S
细胞生物学
凋亡
炎症
发表日期：2014
文献求助 收藏